These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 11550133)

  • 1. Temozolomide for recurrent high-grade glioma.
    Macdonald DR
    Semin Oncol; 2001 Aug; 28(4 Suppl 13):3-12. PubMed ID: 11550133
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Future directions for temozolomide therapy.
    Yung WK
    Semin Oncol; 2001 Aug; 28(4 Suppl 13):43-6. PubMed ID: 11550138
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Survival of patients with recurrent malignant glioma treated with temozolomide: a retrospective observational study.
    Trippoli S; Pelagotti F; Messori A; Vacca F; Vaiani M; Maltoni S
    Drugs R D; 2003; 4(5):285-91. PubMed ID: 12952497
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Temozolomide in malignant gliomas.
    Yung WK
    Semin Oncol; 2000 Jun; 27(3 Suppl 6):27-34. PubMed ID: 10866347
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chemotherapy for the treatment of oligodendroglial tumors.
    Chinot O
    Semin Oncol; 2001 Aug; 28(4 Suppl 13):13-8. PubMed ID: 11550134
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Temozolomide and treatment of malignant glioma.
    Friedman HS; Kerby T; Calvert H
    Clin Cancer Res; 2000 Jul; 6(7):2585-97. PubMed ID: 10914698
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Temozolomide in early stages of newly diagnosed malignant glioma and neoplastic meningitis.
    Friedman HS
    Semin Oncol; 2000 Jun; 27(3 Suppl 6):35-40. PubMed ID: 10866348
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multicenter phase II trial of temozolomide in patients with anaplastic astrocytoma or anaplastic oligoastrocytoma at first relapse. Temodal Brain Tumor Group.
    Yung WK; Prados MD; Yaya-Tur R; Rosenfeld SS; Brada M; Friedman HS; Albright R; Olson J; Chang SM; O'Neill AM; Friedman AH; Bruner J; Yue N; Dugan M; Zaknoen S; Levin VA
    J Clin Oncol; 1999 Sep; 17(9):2762-71. PubMed ID: 10561351
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Temozolomide chemotherapy of patients with recurrent anaplastic astrocytomas and glioblastomas.
    Sipos L; Vitanovics D; Afra D
    Ideggyogy Sz; 2004 Nov; 57(11-12):394-9. PubMed ID: 15662767
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New approaches for temozolomide therapy: use in newly diagnosed glioma.
    Stupp R; Newlands E
    Semin Oncol; 2001 Aug; 28(4 Suppl 13):19-23. PubMed ID: 11550135
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Temozolomide with radiation therapy in high grade brain gliomas: pharmaceuticals considerations and efficacy; a review article.
    Koukourakis GV; Kouloulias V; Zacharias G; Papadimitriou C; Pantelakos P; Maravelis G; Fotineas A; Beli I; Chaldeopoulos D; Kouvaris J
    Molecules; 2009 Apr; 14(4):1561-77. PubMed ID: 19384285
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A first feasibility study of temozolomide for Japanese patients with recurrent anaplastic astrocytoma and glioblastoma multiforme.
    Aoki T; Mizutani T; Ishikawa M; Sugiyama K; Hashimoto N
    Int J Clin Oncol; 2003 Oct; 8(5):301-4. PubMed ID: 14586755
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A phase II study of extended low-dose temozolomide in recurrent malignant gliomas.
    Khan RB; Raizer JJ; Malkin MG; Bazylewicz KA; Abrey LE
    Neuro Oncol; 2002 Jan; 4(1):39-43. PubMed ID: 11772431
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of protracted dose-dense temozolomide in patients with recurrent high-grade glioma.
    Abacioglu U; Caglar HB; Yumuk PF; Akgun Z; Atasoy BM; Sengoz M
    J Neurooncol; 2011 Jul; 103(3):585-93. PubMed ID: 20878446
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Benefits of adjuvant chemotherapy in high-grade gliomas.
    DeAngelis LM
    Semin Oncol; 2003 Dec; 30(6 Suppl 19):15-8. PubMed ID: 14765379
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Temozolomide as a second-line systemic regimen in recurrent high-grade glioma: a phase II study.
    Brandes AA; Ermani M; Basso U; Amistà P; Berti F; Scienza R; Rotilio A; Pinna G; Gardiman M; Monfardini S
    Ann Oncol; 2001 Feb; 12(2):255-7. PubMed ID: 11300334
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Temozolomide: a milestone in neuro-oncology and beyond?
    Mutter N; Stupp R
    Expert Rev Anticancer Ther; 2006 Aug; 6(8):1187-204. PubMed ID: 16925485
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Surgery, radiotherapy and temozolomide in treating high-grade gliomas.
    Parlato C; Barbarisi M; Moraci M; Moraci A
    Front Biosci; 2006 May; 11():1280-3. PubMed ID: 16368514
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Temozolomide: realizing the promise and potential.
    Nagasubramanian R; Dolan ME
    Curr Opin Oncol; 2003 Nov; 15(6):412-8. PubMed ID: 14624222
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The use of temozolomide in recurrent malignant gliomas.
    Gaya A; Rees J; Greenstein A; Stebbing J
    Cancer Treat Rev; 2002 Apr; 28(2):115-20. PubMed ID: 12297119
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.